
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny Inc. has experienced significant growth, as evidenced by a 39% year-over-year increase in egg retrievals and bankings, highlighting the demand for its fertility solutions among women, particularly in the tech sector. The company is poised to capitalize on expanding markets, with potential revenue opportunities stemming from a standard coverage package and the introduction of a fully-insured product offering, especially as more states implement IVF mandates. Furthermore, with near-100% client retention and a growing number of covered lives accessing ancillary services, Progyny appears well-positioned for sustained growth and increased investor confidence moving forward.
Bears say
The financial outlook for Progyny Inc. appears negative due to several fundamental factors, including economic uncertainty and potential unemployment challenges that could discourage individuals from utilizing fertility benefits. Notably, the company has revised its guidance downward, with expected covered lives decreasing from 7.6 million to 7.2 million, contributing to concerns about future revenue growth. Additionally, despite elevated utilization rates, which may have been influenced by large company layoffs, the adjusted EBITDA forecast remains below previous estimates, signaling potential operational weaknesses in a competitive market.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares